TPG GP A, LLC
Follow13F filer, CIK 1903793, FORT WORTH, TX
TPG GP A, LLC reported $2,686,698,455 across 10 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001999371-26-003325
- Period
- 2025-12-31
- Reported value
- $2.69B
- Holdings
- 10
- Top 10 weight
- 100%
- New
- 1
- Sold out
- 0
Part of the filer group TPG GP A, LLC
ANGELO GORDON & CO., L.P.James G. Coulter
- ANGELO GORDON & CO., L.P.
- James G. Coulter
- Jon Winkelried
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BETAnew | +16,395,435 | $463M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
None.
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0001999371-26-003325, largest first. % of portfolio is the value over $2,686,698,455, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| LFSTLIFESTANCE HEALTH GROUP INC | 160,711,618 | $1.13B | 42.11% | 0 | Timeline | ||
| LTHLIFE TIME GROUP HOLDINGS INC | 17,830,652 | $474M | 17.64% | 0 | Timeline | ||
| BETABETA TECHNOLOGIES INC | 16,395,435 | $463M | 17.22% | new | Timeline | ||
| SIONSIONNA THERAPEUTICS INC | 6,744,962 | $277M | 10.33% | 0 | Timeline | ||
| AMRXAMNEAL PHARMACEUTICALS INC | 12,328,767 | $155M | 5.78% | 0 | Timeline | ||
| CBLLCERIBELL INC | 3,967,422 | $87M | 3.24% | 0 | Timeline | ||
| BCAXBICARA THERAPEUTICS INC | 3,010,425 | $50.7M | 1.89% | 0 | Timeline | ||
| ALLOALLOGENE THERAPEUTICS INC | 18,716,306 | $25.6M | 0.95% | 0 | 2026-09-28, 13D/A: 0 shares, 0% of the class, 13D/A filed 2026-09-30 | Timeline | |
| TRTXTPG RE FIN TR INC | 2,392,863 | $20.6M | 0.77% | 0 | Timeline | ||
| RALLYBIO CORPRALLYBIO CORP | 3,028,414 | $2.09M | 0.08% | 0 |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001999371-26-003325 | base | 2026-02-13 | acceptance time not in the bulk data set |